98%
921
2 minutes
20
The National Cancer Institute's (NCI's) Health Information National Trends Survey® (HINTS®) was conceived in 1997 during a multidisciplinary conference focused on risk communication that included attendees representing the fields of psychology, health behavior, health education, public health, clinical medicine, and health journalism. The key recommendation from the conference was for NCI to develop a premiere communication-specific population survey to track health and cancer communication-related phenomena. This led to NCI developing and launching HINTS in 2003. HINTS is a cross-sectional, nationally representative survey of the US noninstitutionalized adult population (18 years and older) that collects data on the public's need for, access to, and use of health- and cancer-related information and health- and cancer-related knowledge, attitudes, and behaviors. As of 2024, HINTS had been administered 17 times over a 21-year period. The resulting datasets can be used for secondary analysis to examine a range of social and behavioral research questions in cancer control and population sciences. The datasets can be examined individually or merged to test for trends over time or to create larger samples for analysis. The evolution of the program has included testing and changing instrument administration modes, oversampling specific populations, and assessing priority constructs, as well as conducting methodological experiments to keep pace with emerging trends in survey research. HINTS has also expanded beyond its cross-sectional format to include data linkages and a longitudinal panel, enabling researchers to address a wider range of research questions. HINTS methods, data products, and impact are discussed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145916 | PMC |
http://dx.doi.org/10.1093/jnci/djae317 | DOI Listing |
Cancer Epidemiol Biomarkers Prev
August 2025
National Cancer Institute, Bethesda, MD, United States.
Background: The Cancer Screening Research Network (CSRN) is a new clinical trials network funded by the National Cancer Institute. The first CSRN study, the Vanguard Study, will assess the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.
Methods: This paper describes the framework NCI developed to engage MCD assay developers, evaluate emerging technologies using biobank reference sets, and select fit-for-purpose MCD assays for inclusion in the Vanguard Study.
Cancer Epidemiol Biomarkers Prev
August 2025
Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
Social determinants of health are known drivers of a broad range of cancer outcomes. These determinants influence factors at the structural and institutional levels of society, which disproportionately affects those living in persistent poverty. Americans living in persistent poverty areas experience higher cancer incidence, delayed cancer diagnosis and treatment, and greater cancer morbidity and mortality.
View Article and Find Full Text PDFPsychol Health
July 2025
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Objectives: Health-related social influence refers to individual efforts to change another person's health beliefs and/or behavior. We sought to understand perspectives on social influence among adult siblings in families with an inherited cancer syndrome, Li-Fraumeni Syndrome (LFS).
Design: An interprofessional team conducted 16 semi-structured interviews with sibling groups ( = 29, aged 18-66, 2-3 siblings per group) enrolled in the NCI's LFS Study.
JAMA Netw Open
July 2025
Columbia University, New York, New York.
Importance: Limited longitudinal data exist regarding health-related quality of life (HRQL) following surgery for ductal carcinoma in situ (DCIS) breast cancer.
Objective: To assess individual- and neighborhood-level factors associated with longitudinal trajectories of mental and physical HRQL among individuals with DCIS eligible for breast conservation surgery.
Design, Setting, And Participants: This cohort study was an ancillary to a prospective, nonrandomized clinical trial of women with DCIS breast cancer between March 2015 and April 2016 at 75 US institutions, community practices, and academic centers coordinated by the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group (E4112).
J Natl Cancer Inst
September 2025
Division of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD, United States.
Background: Improvements in outcomes among children and adolescents diagnosed with cancer are attributable to many factors, including clinical trials such as those administered through the Children's Oncology Group (COG) as well as population-based resources such as the National Childhood Cancer Registry (NCCR). The objective of this study was to link COG trial data with the NCCR to evaluate overall enrollment patterns.
Methods: Data were received from the NCCR and COG that were linked using an array of variables, then compared to evaluate enrollment patterns in COG studies from 2007 to 2018.